Pfizer’s eczema drug meets main goal in mid-stage trial, plans late-stage study

March 9 (Reuters) – U.S. drugmaker Pfizer said on Monday its experimental drug for a chronic skin ​disease met the main ‌goal in a mid-stage study.

Here are some details:

(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by ​Mrigank Dhaniwala)